{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:42:22Z","timestamp":1791852142056,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009032","name":"Pfizer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    continues to cause significant disease burden. Whilst pneumococcal conjugate vaccines (PCV) have substantially reduced this burden, serotype replacement partially negates this success due to increased disease associated with non-vaccine serotypes (NVTs). Continued surveillance is therefore essential to provide crucial epidemiological data. Annual cross-sectional surveillance of paediatric pneumococcal carriage was started in Southampton, UK following PCV7 roll-out in 2006. Nasopharyngeal swabs were collected from children\u2009&lt;\u20095\u00a0years old each winter (October to March) from 2006\/07 and for each consecutive year until 2017\/18. Pneumococcal serotype was inferred from whole genome sequencing data. A total of 1429 (32.5%) pneumococci were isolated from 4093 children. Carriage ranged from 27.8% (95%CI 23.7\u201332.7) in 2008\/09 to 37.9% (95%CI 32.8\u201343.2) in 2014\/15. Analyses showed that carriage increased in children aged 24\u201335\u00a0months (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and 47\u201360\u00a0months (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Carriage of PCV serotypes decreased markedly following PCV7 and\/or PCV13 introduction, apart from serotype 3 where the relative frequency was slightly lower post-PCV13 (pre-PCV13 n\u2009=\u20097, 1.67%; post-PCV13 n\u2009=\u200913, 1.27%). Prevalence of NVTs implicated in increased disease was low with 24F (n\u2009=\u200919, 1.4%) being the most common followed by 9N (n\u2009=\u200911, 0.8%), 8 (n\u2009=\u20097, 0.5%) and 12F (n\u2009=\u20093, 0.2%).\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-17600-6","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T09:04:20Z","timestamp":1659517460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018"],"prefix":"10.1038","volume":"12","author":[{"given":"David W.","family":"Cleary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa T.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"17600_CR1","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","volume":"6","author":"B Wahl","year":"2018","unstructured":"Wahl, B. et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000\u201315. Lancet Glob. Health 6, e744\u2013e757. https:\/\/doi.org\/10.1016\/S2214-109X(18)30247-X (2018).","journal-title":"Lancet Glob. Health"},{"key":"17600_CR2","doi-asserted-by":"publisher","first-page":"e00937","DOI":"10.1128\/mBio.00937-20","volume":"11","author":"F Ganaie","year":"2020","unstructured":"Ganaie, F. et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus. MBio 11, e00937-e920. https:\/\/doi.org\/10.1128\/mBio.00937-20 (2020).","journal-title":"MBio"},{"key":"17600_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3201\/eid2706.204238","volume":"27","author":"M Wasserman","year":"2021","unstructured":"Wasserman, M. et al. Twenty-year public health impact of 7- and 13-valent pneumococcal conjugate vaccines in US children. Emerg. Infect. Dis. 27, 1627\u20131636 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"17600_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P. & George, R. C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: An observational cohort study. Lancet Infect. Dis. 11, 760\u2013768. https:\/\/doi.org\/10.1016\/s1473-3099(11)70090-1 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"17600_CR5","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","volume":"35","author":"G Tsaban","year":"2017","unstructured":"Tsaban, G. & Ben-Shimol, S. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature. Vaccine 35, 2882\u20132891. https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.032 (2017).","journal-title":"Vaccine"},{"key":"17600_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","volume":"18","author":"SN Ladhani","year":"2018","unstructured":"Ladhani, S. N. et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: A prospective national observational cohort study. Lancet Infect. Dis. 18, 441\u2013451. https:\/\/doi.org\/10.1016\/S1473-3099(18)30052-5 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"17600_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.vaccine.2017.01.035","volume":"35","author":"VT Devine","year":"2017","unstructured":"Devine, V. T. et al. The rise and fall of pneumococcal serotypes carried in the PCV era. Vaccine 35, 1293\u20131298. https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.035 (2017).","journal-title":"Vaccine"},{"key":"17600_CR8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","volume":"33","author":"RA Gladstone","year":"2015","unstructured":"Gladstone, R. A. et al. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine 33, 2015\u20132021. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.012 (2015).","journal-title":"Vaccine"},{"key":"17600_CR9","doi-asserted-by":"publisher","first-page":"18977","DOI":"10.1038\/s41598-020-75691-5","volume":"10","author":"A L\u00f8chen","year":"2020","unstructured":"L\u00f8chen, A., Croucher, N. J. & Anderson, R. M. Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. Sci. Rep. 10, 18977. https:\/\/doi.org\/10.1038\/s41598-020-75691-5 (2020).","journal-title":"Sci. Rep."},{"key":"17600_CR10","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","volume":"19","author":"JA Lewnard","year":"2019","unstructured":"Lewnard, J. A. & Hanage, W. P. Making sense of differences in pneumococcal serotype replacement. Lancet Infect. Dis. 19, e213\u2013e220. https:\/\/doi.org\/10.1016\/S1473-3099(18)30660-1 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"17600_CR11","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1016\/j.vaccine.2011.04.004","volume":"29","author":"AS Tocheva","year":"2011","unstructured":"Tocheva, A. S. et al. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine 29, 4400\u20134404. https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.004 (2011).","journal-title":"Vaccine"},{"key":"17600_CR12","unstructured":"Southampton Data Observatory, <https:\/\/data.southampton.gov.uk\/population\/pop-structure\/>"},{"key":"17600_CR13","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2477","volume":"4","author":"G Kapatai","year":"2016","unstructured":"Kapatai, G. et al. Whole genome sequencing of Streptococcus pneumoniae: Development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline. PeerJ 4, e2477. https:\/\/doi.org\/10.7717\/peerj.2477 (2016).","journal-title":"PeerJ"},{"key":"17600_CR14","unstructured":"R: A language and environment for statistical computing. Computing, Vienna, Austria (2017)."},{"key":"17600_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2016)."},{"key":"17600_CR16","unstructured":"Oksanen, J., Blanchet, F., Kindt, R., Legendre, P. & O\u2019Hara, R. Vegan: Community ecology package. R Packag. 2.3-3  (2016)."},{"key":"17600_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001017","volume":"8","author":"S Flasche","year":"2011","unstructured":"Flasche, S. et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: A cross-sectional study. PLoS Med. 8, e1001017. https:\/\/doi.org\/10.1371\/journal.pmed.1001017 (2011).","journal-title":"PLoS Med."},{"key":"17600_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/INF.0000000000001206","volume":"35","author":"R Kaur","year":"2016","unstructured":"Kaur, R., Casey, J. R. & Pichichero, M. E. Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006\u20132015. Pediatr. Infect. Dis. J. 35, 901 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"17600_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cmi.2017.07.018","volume":"24","author":"E Usuf","year":"2018","unstructured":"Usuf, E. et al. Maternal pneumococcal nasopharyngeal carriage and risk factors for neonatal carriage after the introduction of pneumococcal conjugate vaccines in The Gambia. Clin. Microbiol. Infect. 24, 389\u2013395. https:\/\/doi.org\/10.1016\/j.cmi.2017.07.018 (2018).","journal-title":"Clin. Microbiol. Infect."},{"key":"17600_CR20","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/infdis\/jiv167","volume":"212","author":"SA Nzenze","year":"2015","unstructured":"Nzenze, S. A. et al. Temporal changes in pneumococcal colonization in HIV-infected and HIV-uninfected mother-child pairs following transitioning from 7-valent to 13-valent pneumococcal conjugate vaccine, Soweto, South Africa. J. Infect. Dis. 212, 1082\u20131092. https:\/\/doi.org\/10.1093\/infdis\/jiv167 (2015).","journal-title":"J. Infect. Dis."},{"issue":"4","key":"17600_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","volume":"47","author":"I Galanis","year":"2016","unstructured":"Galanis, I. et al. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur. Respir. J. 47(4), 1208\u20131218 (2016).","journal-title":"Eur. Respir. J."},{"key":"17600_CR22","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.eclinm.2022.101271","volume":"44","author":"L Lansbury","year":"2022","unstructured":"Lansbury, L., Lim, B., McKeever, T. M., Lawrence, H. & Lim, W. S. Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis. eClinicalMedicine 44, 101271. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101271 (2022).","journal-title":"eClinicalMedicine"},{"key":"17600_CR23","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/cid\/ciy920","volume":"68","author":"HL Sings","year":"2019","unstructured":"Sings, H. L. et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: A systematic review and meta-analysis of observational studies. Clin. Infect. Dis. 68, 2135\u20132143. https:\/\/doi.org\/10.1093\/cid\/ciy920 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"17600_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/cid\/cit428","volume":"57","author":"R Dagan","year":"2013","unstructured":"Dagan, R. et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: A randomized double-blind trial. Clin. Infect. Dis. 57, 952\u2013962. https:\/\/doi.org\/10.1093\/cid\/cit428 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"17600_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"MR Moore","year":"2015","unstructured":"Moore, M. R. et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance. Lancet Infect. Dis. 15, 301\u2013309. https:\/\/doi.org\/10.1016\/S1473-3099(14)71081-3 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"17600_CR26","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/infdis\/jiz034","volume":"219","author":"H Adler","year":"2019","unstructured":"Adler, H. et al. Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010\u20132017. J. Infect. Dis. 219, 1989\u20131993. https:\/\/doi.org\/10.1093\/infdis\/jiz034 (2019).","journal-title":"J. Infect. Dis."},{"key":"17600_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195799","volume":"13","author":"J Southern","year":"2018","unstructured":"Southern, J. et al. Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England. PLoS ONE 13, e0195799. https:\/\/doi.org\/10.1371\/journal.pone.0195799 (2018).","journal-title":"PLoS ONE"},{"key":"17600_CR28","doi-asserted-by":"publisher","first-page":"e0221525","DOI":"10.1371\/journal.pone.0221525","volume":"14","author":"RC Zanella","year":"2019","unstructured":"Zanella, R. C. et al. Nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in a Brazilian elderly cohort. PLoS ONE 14, e0221525\u2013e0221525. https:\/\/doi.org\/10.1371\/journal.pone.0221525 (2019).","journal-title":"PLoS ONE"},{"key":"17600_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090974","volume":"9","author":"ST Almeida","year":"2014","unstructured":"Almeida, S. T. et al. Low prevalence of pneumococcal carriage and high serotype and genotype diversity among adults over 60 years of age living in Portugal. PLoS ONE 9, e90974. https:\/\/doi.org\/10.1371\/journal.pone.0090974 (2014).","journal-title":"PLoS ONE"},{"key":"17600_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/infdis\/jiz178","volume":"221","author":"R Kandasamy","year":"2020","unstructured":"Kandasamy, R. et al. Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent pneumococcal conjugate vaccine in the United Kingdom. J. Infect. Dis. 221, 1361\u20131370. https:\/\/doi.org\/10.1093\/infdis\/jiz178 (2020).","journal-title":"J. Infect. Dis."},{"key":"17600_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007438","volume":"14","author":"T Azarian","year":"2018","unstructured":"Azarian, T. et al. Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci. PLoS Pathog. 14, e1007438. https:\/\/doi.org\/10.1371\/journal.ppat.1007438 (2018).","journal-title":"PLoS Pathog."},{"key":"17600_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/genes10110845","volume":"10","author":"N Groves","year":"2019","unstructured":"Groves, N. et al. Evolution of Streptococcus pneumoniae serotype 3 in England and Wales: A major vaccine evader. Genes 10, 845. https:\/\/doi.org\/10.3390\/genes10110845 (2019).","journal-title":"Genes"},{"key":"17600_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/inf.0000000000000267","volume":"33","author":"LJ Ricketson","year":"2014","unstructured":"Ricketson, L. J. et al. Trends in asymptomatic nasopharyngeal colonization with Streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada. Pediatr. Infect. Dis. J. 33, 724\u2013730. https:\/\/doi.org\/10.1097\/inf.0000000000000267 (2014).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"17600_CR34","first-page":"575","volume":"55","author":"H \u00d6zdemir","year":"2013","unstructured":"\u00d6zdemir, H. et al. Risk factors for nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of heptavalent pneumococcal conjugate vaccine (PCV7) to the national vaccine schedule. Turk. J. Pediatr. 55, 575\u2013583 (2013).","journal-title":"Turk. J. Pediatr."},{"key":"17600_CR35","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(04)16357-5","volume":"363","author":"D Bogaert","year":"2004","unstructured":"Bogaert, D. et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. The Lancet 363, 1871\u20131872. https:\/\/doi.org\/10.1016\/S0140-6736(04)16357-5 (2004).","journal-title":"The Lancet"},{"key":"17600_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064731","volume":"8","author":"NJ Loman","year":"2013","unstructured":"Loman, N. J. et al. Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine. PLoS ONE 8, e64731. https:\/\/doi.org\/10.1371\/journal.pone.0064731 (2013).","journal-title":"PLoS ONE"},{"key":"17600_CR37","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/gbe\/evw066","volume":"8","author":"DW Cleary","year":"2016","unstructured":"Cleary, D. W. et al. Comparative genomics of carriage and disease isolates of Streptococcus pneumoniae serotype 22F reveals lineage-specific divergence and niche adaptation. Genome Biol. Evol. 8, 1243\u20131251. https:\/\/doi.org\/10.1093\/gbe\/evw066 (2016).","journal-title":"Genome Biol. Evol."},{"key":"17600_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.587730","author":"C Chaguza","year":"2021","unstructured":"Chaguza, C. et al. Carriage dynamics of pneumococcal serotypes in naturally colonized infants in a rural African setting during the first year of life. Front. Pediatr. https:\/\/doi.org\/10.3389\/fped.2020.587730 (2021).","journal-title":"Front. Pediatr."},{"key":"17600_CR39","doi-asserted-by":"publisher","first-page":"23809","DOI":"10.1038\/srep23809","volume":"6","author":"AL Wyllie","year":"2016","unstructured":"Wyllie, A. L. et al. Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines. Sci. Rep. 6, 23809. https:\/\/doi.org\/10.1038\/srep23809 (2016).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17600-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17600-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17600-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:58:23Z","timestamp":1669334303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17600-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17600"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17600-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DWC was a post-doctoral researcher on GSK funded projects in 2014\/15, and currently receives grant support from Pfizer and the National Institute for Health via the NIHR Southampton Biomedical Research Centre. SNF receives support from the National Institute for Health Research funding via the NIHR Southampton Wellcome Trust Clinical Research Facility and the NIHR Southampton Biomedical Research Centre. SNF and SCC act as principal investigators for clinical trials and other studies conducted on behalf of University Hospital Southampton NHS Foundation Trust\/University of Southampton that are sponsored by vaccine manufacturers. No personal payments are received from them. SNF, JMJ and SCC have participated in advisory boards for vaccine manufacturers but receive no personal payments for this work. SNF, SCC and JMJ have received financial assistance from vaccine manufacturers to attend conferences. All grants and honoraria are paid into accounts within the respective NHS Trusts or Universities, or to independent charities. RAG, VTD and JJ received PhD studentships via the University of Southampton from Pfizer. RAG received post-doctoral support in 2012 on a GSK funded research project via the University of Southampton. KLO received PhD studentship support from GSK, again via the University of Southampton. All other authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13332"}}